GAMMA Investing LLC Has $1.86 Million Stake in CME Group Inc. (NASDAQ:CME)

GAMMA Investing LLC grew its position in CME Group Inc. (NASDAQ:CME - Free Report) by 24.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,007 shares of the financial services provider's stock after purchasing an additional 1,381 shares during the period. GAMMA Investing LLC's holdings in CME Group were worth $1,859,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of CME Group during the fourth quarter valued at about $1,107,389,000. Price T Rowe Associates Inc. MD lifted its stake in shares of CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares during the period. Raymond James Financial Inc. bought a new position in shares of CME Group in the fourth quarter valued at approximately $871,063,000. Capital Wealth Planning LLC increased its stake in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock valued at $565,671,000 after acquiring an additional 996,498 shares during the period. Finally, Egerton Capital UK LLP bought a new position in CME Group during the 4th quarter valued at $223,967,000. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Trading Down 0.4%

NASDAQ CME traded down $0.98 on Monday, hitting $273.79. 177,569 shares of the stock were exchanged, compared to its average volume of 2,200,314. The company's 50-day moving average price is $275.21 and its two-hundred day moving average price is $256.83. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $193.17 and a 52-week high of $290.79. The company has a market capitalization of $98.66 billion, a price-to-earnings ratio of 27.54, a P/E/G ratio of 3.73 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.50 EPS. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.83%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is 50.30%.

Insider Transactions at CME Group

In other news, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction dated Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the sale, the director now owns 38,651 shares in the company, valued at approximately $10,207,729.10. This represents a 4.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director now owns 2,915 shares of the company's stock, valued at approximately $790,781.20. This trade represents a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock worth $3,680,610 in the last 90 days. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Bank of America boosted their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Barclays raised their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 23rd. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Finally, Royal Bank Of Canada restated a "sector perform" rating and set a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and an average target price of $258.20.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.